Top

Environmental Health and Preventive Medicine

Published in:

Open Access 01-12-2020 | Severe Acute Respiratory Syndrome Coronavirus | Review article

Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control

Authors: Kenichi Azuma, U Yanagi, Naoki Kagi, Hoon Kim, Masayuki Ogata, Motoya Hayashi

Published in: Environmental Health and Preventive Medicine | Issue 1/2020

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new zoonotic agent that emerged in December 2019, causes coronavirus disease 2019 (COVID-19). This infection can be spread by asymptomatic, presymptomatic, and symptomatic carriers. SARS-CoV-2 spreads primarily via respiratory droplets during close person-to-person contact in a closed space, especially a building. This article summarizes the environmental factors involved in SARS-CoV-2 transmission, including a strategy to prevent SARS-CoV-2 transmission in a building environment. SARS-CoV-2 can persist on surfaces of fomites for at least 3 days depending on the conditions. If SARS-CoV-2 is aerosolized intentionally, it is stable for at least several hours. SARS-CoV-2 is inactivated rapidly on surfaces with sunlight. Close-contact aerosol transmission through smaller aerosolized particles is likely to be combined with respiratory droplets and contact transmission in a confined, crowded, and poorly ventilated indoor environment, as suggested by some cluster cases. Although evidence of the effect of aerosol transmission is limited and uncertainty remains, adequate preventive measures to control indoor environmental quality are required, based on a precautionary approach, because COVID-19 has caused serious global damages to public health, community, and the social economy. The expert panel for COVID-19 in Japan has focused on the “3 Cs,” namely, “closed spaces with poor ventilation,” “crowded spaces with many people,” and “close contact.” In addition, the Ministry of Health, Labour and Welfare of Japan has been recommending adequate ventilation in all closed spaces in accordance with the existing standards of the Law for Maintenance of Sanitation in Buildings as one of the initial political actions to prevent the spread of COVID-19. However, specific standards for indoor environmental quality control have not been recommended and many scientific uncertainties remain regarding the infection dynamics and mode of SARS-CoV-2 transmission in closed indoor spaces. Further research and evaluation are required regarding the effect and role of indoor environmental quality control, especially ventilation.

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–9.CrossRef

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.CrossRef

Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221–4.CrossRef

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.CrossRef

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.CrossRef

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–2.CrossRef

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.CrossRef

Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020:ciaa272. https://doi.org/10.1093/cid/ciaa272.

WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Geneva: World Health Organization; 2020.

10.

Cheng VCC, Wong SC, Chen JHK, Yip CCY, Chuang VWM, Tsang OTY, Sridhar S, Chan JFW, Ho PL, Yuen KY. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol. 2020;41:493–8.CrossRef

11.

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. https://doi.org/10.1016/j.ijantimicag.2020.CrossRef

12.

Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, Worlock KB, Yoshida M, Barnes JL. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–7.CrossRef

13.

WHO. Transmission of SARS-CoV-2: implications for infection prevention precautions. Scientific brief on 9 July 2020. Geneva: World Health Organization; 2020.

14.

Morawska L, Cao J. Airborne transmission of SARS-CoV-2: the world should face the reality. Environ Int. 2020;139:105730. https://doi.org/10.1016/j.envint.2020.105730.CrossRef

15.

Guo ZD, Wang ZY, Zhang SF, Li X, Li L, Li C, Cui Y, Fu RB, Dong YZ, Chi XY, Zhang MY, Liu K, Cao C, Liu B, Zhang K, Gao YW, Lu B, Chen W. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis. 2020;26:1583–91.CrossRef

16.

Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, Sun L, Duan Y, Cai J, Westerdahl D, Liu X, Xu K, Ho KF, Kan H, Fu Q, Lan K. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 2020;582:557–60.CrossRef

17.

Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, surface environmental, and personal protective equipment contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323:1610–2.CrossRef

18.

West R, Michie S, Rubin GJ, Amlôt R. Applying principles of behaviour change to reduce SARS-CoV-2 transmission. Nat Hum Behav. 2020;4:451–9.CrossRef

19.

Wu S, Wang Y, Jin X, Tian J, Liu J, Mao Y. Environmental contamination by SARS-CoV-2 in a designated hospital for Coronavirus Disease 2019. Am J Infect Control. 2020:S0196-6553(20)30275-3. https://doi.org/10.1016/j.ajic.2020.05.003.

20.

Ye G, Lin H, Chen S, Wang S, Zeng Z, Wang W, Zhang S, Rebmann T, Li Y, Pan Z, Yang Z, Wang Y, Wang F, Qian Z, Wang X. Environmental contamination of SARS-CoV-2 in healthcare premises. J Infect. 2020:S0163-4453(20)30260-7. https://doi.org/10.1016/j.jinf.2020.04.034.

21.

Nicas M, Sun G. An integrated model of infection risk in a health care environment. Risk Anal. 2006;26:1097–108.CrossRef

22.

Nicas M, Jones RM. Relative contributions of four exposure pathways to influenza infection risk. Risk Anal. 2009;29:1292–303.CrossRef

23.

Tellier R, Li Y, Cowling BJ, Tang JW. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis. 2019;19:101. https://doi.org/10.1186/s12879-019-3707-y.CrossRef

24.

Azuma K, Kagi N, Kim H, Hayashi M. Impact of climate and ambient air pollution on the epidemic growth during COVID-19 outbreak in Japan. Environ Res. 2020;190:110042. https://doi.org/10.1016/j.envres.2020.110042.CrossRef

25.

Aboubakr HA, Sharafeldin TA, Goyal SM. Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review. Transbound Emerg Dis. 2020. https://doi.org/10.1111/tbed.13707.

26.

Moriarty LF, Plucinski MM, Marston BJ, Kurbatova EV, Knust B, Murray EL, et al. Public health responses to COVID-19 outbreaks on cruise ships - worldwide, February - March 2020. MMWR. 2020;69:347–52.

27.

Taskforce for the COVID-19 Cruise Ship Outbreak. Environmental sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during a coronavirus disease (COVID-19) outbreak aboard a commercial cruise ship. medRxiv. 2020. https://doi.org/10.1101/2020.05.02.20088567.

28.

van Doremalen N, Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B, Lloyd-Smith J. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. N Engl J Med. 2020;382:1564–7.CrossRef

29.

Smither SJ, Eastaugh LS, Findlay JS, Lever MS. Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity. Emerg Microbes Infect. 2020;9:1415–7.CrossRef

30.

Chin AWH, Chu JTS, Perera MRA, Hui KPY, Yen HL, Chan MCW, Peiris M, Poon LLM. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020. https://doi.org/10.1016/S2666-5247(20)30003-3.

31.

Duan SM, Zhao XS, Wen RF, Huang JJ, Pi GH, Zhang SX, et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16:246–55.

32.

Ratnesar-Shumate S, Williams G, Green B, Krause M, Holland B, Wood S, Bohannon J, Boydston J, Freeburger D, Hooper I, Beck K, Yeager J, Altamura LA, Biryukov J, Yolitz J, Schuit M, Wahl V, Hevey M, Dabisch P. Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces. J Infect Dis. 2020;222:214–22.CrossRef

33.

Schuit M, Ratnesar-Shumate S, Yolitz J, Williams G, Weaver W, Green B, Miller D, Krause M, Beck K, Wood S, Holland B, Bohannon J, Freeburger D, Hooper I, Biryukov J, Altamura LA, Wahl V, Hevey M, Dabisch P. Airborne SARS-CoV-2 is rapidly inactivated by simulated sunlight. J Infect Dis. 2020:jiaa334. https://doi.org/10.1093/infdis/jiaa334.

34.

Michels H, Moran W, Michel J. Antimicrobial properties of copper alloy surfaces, with a focus on hospital-acquired infections. Int J Metalcasting. 2008;2:47–56.CrossRef

35.

Warnes SL, Keevil CW. Inactivation of norovirus on dry copper alloy surfaces. PLoS One. 2013;8(9):e75017. https://doi.org/10.1371/journal.pone.0075017.CrossRef

36.

Karpanen TJ, Casey AL, Lambert PA, Cookson BD, Nightingale P, Miruszenko L, Elliott TSJ. The antimicrobial efficacy of copper alloy furnishing in the clinical environment: a crossover study. Infect Control Hosp Epidemiol. 2012;33:3–9.CrossRef

37.

Montero DA, Arellano C, Pardo M, Vera R, Gálvez R, Cifuentes M, Berasain MA, Gómez M, Ramírez C, Vidal RM. Antimicrobial properties of a novel copperbased composite coating with potential for use in healthcare facilities. Antimicrob Resist Infect Control. 2019;8:3. https://doi.org/10.1186/s13756-018-0456-4.CrossRef

38.

Pastorino B, Touret F, Gilles M, de Lamballerie X, Charrel RN. Prolonged viability of SARS-CoV-2 in fomites. Emerg Infect Dis. 2020;26(9). https://doi.org/10.3201/eid2609.201788.

39.

Biryukov J, Boydston JA, Dunning RA, Yeager JJ, Wood S, Reese AL, Ferris A, Miller D, Weaver W, Zeitouni NE, Phillips A, Freeburger D, Hooper I, Ratnesar-Shumate S, Yolitz J, Krause M, Williams G, Dawson DG, Herzog A, Dabisch P, Wahl V, Hevey MC, Altamura LA, Frieman MB. Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces. mSphere. 2020. https://doi.org/10.1128/mSphere.00441-20.

40.

Memarzadeh F. Literature review of the effect of temperature and humidity on viruses. ASHRAE Trans. 2012;118:1049–60.

41.

Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130. https://doi.org/10.1186/1471-2334-6-130.CrossRef

42.

WHO. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. Geneva: World health Organization; 2020. [cited March 29, 2020]. Available at: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. Accessed 31 Aug 2020.

43.

Morawska L, Tang JW, Bahnfleth W, Bluyssen PM, Boerstra A, Buonanno G, Cao J, Dancer S, Floto A, et al. How can airborne transmission of COVID-19 indoors be minimised? Environ Int. 2020;142:105832. https://doi.org/10.1016/j.envint.2020.105832.CrossRef

44.

Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92:235–50.CrossRef

45.

Bao L, Gao H, Deng W, Lv Q, Yu H, Liu M, Yu P, Liu J, Qu Y, Gong S, Lin K, Qi F, Xu Y, Li F, Xiao C, Xue J, Song Z, Xiang Z, Wang G, Wang S, Liu X, Zhao W, Han Y, Wei Q, Qin C. Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice. J Infect Dis. 2020:jiaa281. https://doi.org/10.1093/infdis/jiaa281.

46.

Bontempi E. First data analysis about possible COVID-19 virus airborne diffusion due to air particulate matter (PM): The case of Lombardy (Italy). Environ Res. 2020;186:109639. https://doi.org/10.1016/j.envres.2020.109639.CrossRef

47.

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19). JAMA. 2020. https://doi.org/10.1001/jama.2020.12839.

48.

Johnson GR, Morawska L, Ristovski ZD, Hargreaves M, Mengersen K, Chao CYH, Wan MP, Li Y, Xie X, Katoshevski D, Corbett S. Modality of human expired aerosol size distributions. J Aerosol Sci. 2011;42:839–51.CrossRef

49.

Asadi S, Wexler AS, Cappa CD, Barreda S, Bouvier NM, Ristenpart WD. Aerosol emission and superemission during human speech increase with voice loudness. Sci Rep. 2019;9:2348. https://doi.org/10.1038/s41598-019-38808-z.CrossRef

50.

Rahmani AR, Leili M, Azarian G, Poormohammadi A. Sampling and detection of corona viruses in air: a mini review. Sci Total Environ. 2020;740:140270. https://doi.org/10.1016/j.scitotenv.2020.140207.CrossRef

51.

Qian J, Peccia J, Ferro AR. Walking-induced particle resuspension in indoor environments. Atmos Environ. 2014;89:464–81.CrossRef

52.

Rosati JA, Thornburg J, Rodes C. Resuspension of particulate matter from carpet due to human activity. Aerosol Sci Technol. 2008;42:472–82.CrossRef

53.

Furuse Y, Sando E, Tsuchiya N, Miyahara R, Yasuda I, Ko YK, et al. Clusters of coronavirus disease in communities, Japan, January–April 2020. Emerg Infect Dis. 2020. https://doi.org/10.3201/eid2609.202272.

54.

Nishiura H, Oshitani H, Kobayashi T, Saito T, Sunagawa T, Matsui T, Wakita T, MHLW COVID-19 Response Team, Motoi Suzuki. Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19), medRxiv preprint; 2020. p. 0029272. https://doi.org/10.1101/2020.02.28.20029272.CrossRef

55.

Lu J, Gu J, Li K, Xu C, Su W, Lai Z, et al. COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China. Emerg Infect Dis. 2020. https://doi.org/10.3201/eid2607.200764.

56.

Li Y, Qian H, Hang J, Chen X, Hong L, Liang P, Li J, Xiao S, Wei J, Liu L, Kang M. Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant. medRxiv preprint. 2020. https://doi.org/10.1101/2020.04.16.20067728.

57.

Park SY, Kim YM, Yi S, Lee S, Na BJ, Kim CB, et al. Coronavirus disease outbreak in call center, South Korea. Emerg Infect Dis. 2020. https://doi.org/10.3201/eid2608.201274.

58.

Hamner L, Dubbel P, Capron I, Ross A, Jordan A, Lee J, Lynn J, Ball A, Narwal S, Russell S, Patrick D, Leibrand H. High SARS-CoV-2 attack rate following exposure at a choir practice — Skagit county, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:606–10.CrossRef

59.

Guenther T, Czech-Sioli M, Indenbirken D, Tenhaken P, Exner M, Ottinger M, Fischer N, Grundhoff A, Brinkmann M. Investigation of a superspreading event preceding the largest meat processing plant-related SARS-Coronavirus 2 outbreak in Germany. SSRN; 2020. https://doi.org/10.2139/ssrn.3654517.CrossRef

60.

WHO. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014.

61.

Xu R, Cui B, Duan X, Zhang P, Zhou X, Yuan Q. Saliva: potential diagnostic value and transmission of 2019-nCoV. Int J Oral Sci. 2020;12:11. https://doi.org/10.1038/s41368-020-0080-z.CrossRef

62.

Hayashi M, Yanagi U, Azuma K, Kagi N, Ogata M, Morimoto S, Hayama H, Mori T, Kikuta K, Tanabe S, Kurabuchi T, Yamada H, Kobayashi K, Kim H, Kaihara N. Measures against COVID-19 concerning Summer Indoor Environment in Japan. Jpn Archit Rev. 2020;00:e12183. https://doi.org/10.1002/2475-8876.12183.CrossRef

63.

Mikhailov E, Vlasenko S, Niessner R, Pöschl U. Interaction of aerosol particles composed of protein and salts with water vapor: hygroscopic growth and microstructural rearrangement. Atmos Chem Phys. 2004;4:323–50.CrossRef

64.

Ukai M, Nobe T. Study on thermal environmental ununiformity in office buildings. J Environ Eng AIJ. 2017;82:739–46.CrossRef

65.

Nakano J, et al. Survey on control of indoor air environment in office buildings: Part5 evaluation of thermal environment by domestic and international standards. In: Proceeding of the annual conference of The Society of Heating, Air-Conditioning and Sanitary Engineers of Japan (SHASE); 2019. p. 61–4.

66.

Nardell EA. Wells revisited: infectious particles vs. quanta of mycobacterium tuberculosis infection–don’t get them confused. Mycobact Dis. 2016;6(5):1000231. https://doi.org/10.4172/2161-1068.1000231.CrossRef

67.

Rudnick SN, Milton DK. Risk of indoor airborne infection transmission estimated from carbon dioxide concentration. Indoor Air. 2003;13:237–45.CrossRef

68.

Liao CM, Chang CF, Liang HM. A probabilistic transmission dynamic model to assess indoor airborne infection risks. Risk Anal. 2005;25:1097–107.CrossRef

69.

Beggs CB, Shepherd SJ, Kerr KG. Potential for airborne transmission of infection in the waiting areas of healthcare premises: stochastic analysis using a Monte Carlo model. BMC Infect Dis. 2010;10:247. https://doi.org/10.1186/1471-2334-10-247.CrossRef

70.

Sze To GN, Chao CYH. Review and comparison between the Wells-Riley and dose response approaches to risk assessment of infectious respiratory diseases. Indoor Air. 2010;20:2–16.CrossRef

71.

Nardell EA, Keegan J, Cheney SA, Etkind SC. Airborne infection. Theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis. 1991;144:302–6.CrossRef

72.

Escombe AR, Oeser C, Gilman RH, Navincopa M, Ticona E, Martínez C, Caviedes L, Sheen P, Gonzalez A, Noakes C, Moore DAJ, Friedland JS, Evans CA. The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis. 2007;44:1349–57.CrossRef

73.

Chen SC, Liao CM, Li SS, You SH. A probabilistic transmission model to assess infection risk from mycobacterium tuberculosis in commercial passenger trains. Risk Anal. 2011;31:930–9.CrossRef

74.

Qian H, Li Y, Nielsen PV, Huang X. Spatial distribution of infection risk of SARS transmission in a hospital ward. Build Environ. 2009;44:1651–8.CrossRef

75.

Riley EC, Murphy G, Riley RL. Airborne spread of measles in a suburban elementary school. Am J Epidemiol. 1978;107:421–32.CrossRef

76.

Riley RL, Nardell EA. Cleaning the air: the theory and application of ultraviolet air disinfection. Am Rev Respir Dis. 1989;139:1286–94.CrossRef

77.

Stephens B. HVAC filtration and the Wells-Riley approach to assessing risks of infectious airborne diseases. NAFA Foundation Report, 2012.

78.

Dai H, Zhao B. Association of infected probability of COVID-19 with ventilation rates in confined spaces: a Wells-Riley equation based investigation. medRxiv. 2020. https://doi.org/10.1101/2020.04.21.20072397.

79.

Chao CYH, Wan MP, Morawska L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Li Y, Xie X, Katoshevski D. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci. 2009;40:122–33.CrossRef

80.

Morawska L, Johnson GR, Ristovski ZD, et al. Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. J Aerosol Sci. 2009;40:256–69.CrossRef

81.

Ai ZT, Melikov AK. Airborne spread of expiratory droplet nuclei between the occupants of indoor environments: A review. Indoor Air. 2018;28:500–24.CrossRef

82.

ASHRAE. ASHRAE position document on airborne infectious diseases. Atlanta: American Society of Heating, Refrigerating and Air-Conditioning Engineers, Inc.; 2020.

83.

Azimi P, Stephens B. HVAC filtration for controlling infectious airborne disease transmission in indoor environments: predicting risk reductions and operational costs. Build Environ. 2013;70:150–60.CrossRef

84.

Reed NG. The history of ultraviolet germicidal irradiation for air disinfection. Public Health Rep. 2010;125:15–27.CrossRef

85.

CDC. Guidelines for environmental infection control in health-care facilities. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.

86.

ASHRAE. ASHRAE position document on infectious aerosols. Atlanta: American Society of Heating, Refrigerating and Air-Conditioning Engineers, Inc.; 2020.

87.

Brickner PW, Vincent RL, First M, Nardell E, Kaufman W. The application of ultraviolet germicidal irradiation to control transmission of airborne disease: bioterrorism countermeasure. Public Health Rep. 2003;118:99–114.CrossRef

88.

Tseng CC, Li CS. Inactivation of virus-containing aerosols by ultraviolet germicidal irradiation. Aerosol Sci Technol. 2005;39:1136–42.CrossRef

89.

Jensen MM. Inactivation of airborne viruses by ultraviolet irradiation. Appl Microbiol. 1964;12:418–20.CrossRef

90.

Kowalski WJ, Bahnfleth WP, Whittam TS. Filtration of airborne microorganisms: modeling and prediction. ASHRAE Trans. 1999;105:4–17.

91.

Kowalski WJ. Immune building systems technology. New York: McGraw-Hill; 2002.

92.

Levetin E, Shaughnessy R, Rogers CA, Scheir R. Effectiveness of germicidal UV radiation for reducing fungal contamination within air-handling units. Appl Environ Microbiol. 2001;67:3712–5.CrossRef

93.

Menzies D, Popa J, Hanley JA, Rand T, Milton DK. Effect of ultraviolet germicidal lights installed in office ventilation systems on workers’ health and wellbeing: double-blind multiple crossover trial. Lancet. 2003;362:1785–91.CrossRef

94.

PMJHC. 16th meeting document (March 1, 2020). Tokyo: National Task Force for COVID-19 Outbreak in Japan, Prime Minister of Japan and His Cabinet; 2020. Available at: https://www.kantei.go.jp/jp/singi/novel_coronavirus/th_siryou/sidai_r020301.pdf. Assessed 31 Aug 2020. (In Japanese).

95.

Furuse Y, Ko YK, Saito M, Shobugawa Y, Jindai K, Saito T, Nishiura H, Sunagawa T, Suzuki M, National Task Force for COVID-19 Outbreak in Japan. Epidemiology of COVID-19 outbreak in Japan, January–March 2020. Japanese J Infect Dis 2020. doi: https://doi.org/10.7883/yoken.JJID.2020.271.

96.

PMJHC. 21th meeting document (March 20, 2020). Tokyo: National Task Force for COVID-19 Outbreak in Japan, Prime Minister of Japan and His Cabinet; 2020. Available at: https://www.kantei.go.jp/jp/singi/novel_coronavirus/th_siryou/sidai_r020320.pdf. Assessed 31 Aug 2020. (In Japanese).

97.

MHLW. Ventilation to improve “closed spaces with poor ventilation” in commercial facilities (March 30, 2020). Tokyo: Ministry of Health, Labour and Welfare; 2020. Available at: https://www.mhlw.go.jp/content/10900000/000616069.pdf. Assessed 31 Aug 2020. (In Japanese).

98.

MHLW. Measures to prevent the large-scale spread of COVID-19 in workplaces (March 31, 2020). No. 0331-2. Tokyo: Ministry of Health, Labour and Welfare; 2020. Available at: https://www.mhlw.go.jp/content/11303000/000617466.pdf. Assessed 31 Aug 2020. (In Japanese).

99.

MHLW. Maintenance of air-conditioning and ventilation systems in specific buildings (April 2, 2020). Tokyo: Ministry of Health, Labour and Welfare; 2020. Available at: https://www.mhlw.go.jp/content/11130500/000650594.pdf. Assessed 31 Aug 2020. (In Japanese).

100.

MHLW. Methods of ventilation for improving “closed spaces with poor ventilation” (April 3, 2020). Tokyo: Ministry of Health, Labour and Welfare; 2020. Available at: https://www.mhlw.go.jp/content/10900000/000618969.pdf. Assessed 31 Aug 2020. (In Japanese).

101.

Menzies D, Fanning A, Yuan L, FitzGerald JM. Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Canadian Collaborative Group in Nosocomial Transmission of TB. Ann Intern Med. 2000;133:779–89.CrossRef

102.

Toyota M. Environmental factors relating to a mass outbreak of tuberculosis in a junior high school. Kekkaku. 2003;78:11–6. https://doi.org/10.11400/kekkaku1923.78.733 (in Japanese with English abstract).CrossRef

103.

Watase H. In association with tuberculous group infection in cram school: effect of ventilation on the infection risk. Kekkaku. 2010;85:591–3 https://www.kekkaku.gr.jp/pub/Vol.85(2010)/Vol85_No7/Vol85No7P591-593.pdf (in Japanese).

104.

Bloch AB, Orenstein WA, Ewing WM, Spain WH, Mallison GF, Herrmann KL, Hinman AR. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics. 1985;75:676–83.

105.

EMNCDC. Analysis of the response to the novel coronavirus disease (COVID-19) and recommendations (May 29, 2020). Tokyo: Expert Meeting on Novel Coronavirus Disease Control. Available at: https://www.mhlw.go.jp/content/10900000/000629000.pdf. Assessed 31 Aug 2020. (In Japanese).

106.

MHLW. Action for prevention of heatstroke in 2020 (May 26, 2020). Tokyo: Ministry of Health, Labour and Welfare; 2020. Available at: https://www.mhlw.go.jp/content/000633494.pdf. Assessed 31 Aug 2020. (In Japanese).

107.

MHLW. Ventilation for improving “closed spaces with poor ventilation” with prevention of heatstroke (June 17, 2020). Tokyo: Ministry of Health, Labour and Welfare; 2020. Available at: https://www.mhlw.go.jp/content/10900000/000640920.pdf. Assessed 31 Aug 2020. (In Japanese).

108.

MHLW. Methods of ventilation for improving “closed spaces with poor ventilation” with prevention of heatstroke for owners using air-conditioning system without ventilation in commercial facilities (June 24, 2020). Tokyo: Ministry of Health, Labour and Welfare; 2020. Available at: https://www.mhlw.go.jp/content/10900000/000640913.pdf. Assessed 31 Aug 2020. (In Japanese).

109.

Yanagi U, Kurabuchi T, Hayashi M, Ogata M, Tanabe S, Otsuka M. Is COVID-19 spread by air conditioning or ventilation? (June 15, 2020). Tokyo: Society of Heating, Air-Conditioning and Sanitary Engineers of Japan; 2020. Available at: http://www.shasej.org/oshirase/2006/covid19v2.pdf/. Assessed 31 Aug 2020 (In Japanese).

110.

Cabinet Secretariat. COVID-19 information and resources. Tokyo: Cabinet Secretariat; 2020. Available at: https://corona.go.jp/en/. Assessed 31 Aug 2020.

111.

United Nations. Report of the United Nations conference on environment and development. A/CONF.151/26 (Vol. I). New York: United Nations; 1992.

112.

Goldstein BD. The precautionary principle also applies to public health actions. Am J Public Health. 2001;91:1358–61.CrossRef

113.

Chaudry RV. The precautionary principle, public health, and public health nursing. Public Health Nurs. 2008;25:261–8.CrossRef

114.

WHO Europe. The precautionary principle: protecting public health, the environment and the future of our children. Copenhagen: World Health Organization Regional Office for Europe; 2004.

115.

EC. Communication from the commission on the precautionary principle. Brussels: Commission of the European Communities; 2000.

Title: Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control
Authors: Kenichi Azuma
U Yanagi
Naoki Kagi
Hoon Kim
Masayuki Ogata
Motoya Hayashi
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Severe Acute Respiratory Syndrome Coronavirus
SARS-CoV-2
COVID-19
Published in: Environmental Health and Preventive Medicine / Issue 1/2020
Print ISSN: 1342-078X
Electronic ISSN: 1347-4715
DOI: https://doi.org/10.1186/s12199-020-00904-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

Mental health and related influencing factors among rural elderly in 14 poverty state counties of Chongqing, Southwest China: a cross-sectional study

Effects of the built environment on physical activity: a systematic review of longitudinal studies taking sex/gender into account

Household heating associated with disability in activities of daily living among Chinese middle-aged and elderly: a longitudinal study

Association between surgical procedures under general anesthesia in infancy and developmental outcomes at 1 year: the Japan Environment and Children’s Study

Reduction in inequalities in health insurance coverage and healthcare utilization among older adults in the Philippines after mandatory national health insurance coverage: trend analysis for 2003–2017

Review of the health benefits of habitual consumption of miso soup: focus on the effects on sympathetic nerve activity, blood pressure, and heart rate